Business
Enveric Biosciences Announces Reverse Stock Split
CAMBRIDGE, Mass., October 23, 2025--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. The reverse stock split will become effective at 8:00 a.m., New York time, on Tuesday, October 28, 2025. Enveric’s co
About this update from Enveric Biosciences, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/cdd35429f88a592273d28ab4635f500d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3MF5ljWD4dxiT2xs5G1pEg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/cdd35429f88a592273d28ab4635f500d","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/wCWboe3ErTDq164DOFK.BA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/cdd35429f88a592273d28ab4635f500d","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Common Stock Will Begin Trading on a Split-Adjusted Basis on October 28, 2025","length":77,"tagName":"p","attribs":{}},{"type":"text","content":"CAMBRIDGE, Mass., October 23, 2025--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. The reverse stock split will become effective at 8:00 a.m., New York time, on Tuesday, October 28, 2025. Enveric’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol "ENVB" and will begin trading on a split-adjusted basis when the market opens on Tuesday, October 28, 2025.","length":738,"tagName":"p"},{"type":"text","content":"At the Company’s annual meeting of stockholders on May 29, 2025, the Company’s stockholders conditionally approved an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), to effect a reverse stock split of the Company’s Common Stock at a ratio in the range of 1-for-5 to 1-for-50, upon the Company receiving a delisting determination from the Nasdaq Capital Market ("Nasdaq’) for failure to maintain the required minimum bid price, with such ratio to be determined by the Company’s board of directors (the "Board") and included in a public announcement. On October 22, 2025, the Company r...